Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR T-cell immunoreceptor with Ig and ITIM domains inhibitor Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650411